Benzenamine, reaction products with aniline hydrochloride and nitrobenzene, hydrochlorides

Endpoint summary

Key value for chemical safety assessment

Effects on fertility

Link to relevant study records

Reference

Reference 1

Endpoint:

screening for reproductive / developmental toxicity

Remarks:

based on test type (migrated information)

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: Test method according to OECD Guideline 422. GLP study.

Qualifier:

according to guideline

Guideline:

OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)

GLP compliance:

yes

Limit test:

no

Species:

rat

Strain:

Crj: CD(SD)

Sex:

male/female

Details on test animals or test system and environmental conditions:

- Age at study initiation: 10 weeks old

Route of administration:

oral: gavage

Vehicle:

other: Methylcellulose aqueous solution

Details on exposure:

VEHICLE
- Amount of vehicle (if gavage): 5 mL/kg
- 0.5%w/v Methylcellulose aqueous solution (suspended)

Analytical verification of doses or concentrations:

not specified

Duration of treatment / exposure:

Males: 42 days (from 14 days before mating, and through the mating period until a day before necropsy).
Females: 41-48 days (from 14 days before mating, and through the mating period until day 4 of lactation).

Frequency of treatment:

Daily

Remarks:

Doses / Concentrations:
0 (control), 40, 200 and 1000 mg/kg bw/day
Basis:
nominal conc.

No. of animals per sex per dose:

Males: 7 (control), 12 (40 mg/kg bw/day), 12 (200 mg/Kg bw/day), 7 (1000 mg/kg bw/day), 5 (control with recovery), 5 (1000 mg/kg bw/day with recovery).
Females: 12 (control), 11 (40 mg/kg bw/day), 11 (200 mg/Kg bw/day), 12 (1000 mg/kg bw/day), 5 (control with recovery), 5 (1000 mg/kg bw/day with recovery).

Control animals:

yes, concurrent vehicle

Details on study design:

- Dose selection rationale: In the 14-day range finding study with 5 males and 5 females at dose levels of 0, 100, 300, 1000 mg/kg/day, there were no changes attributed to the treatment at any groups. (Inspection items: clinical signs, body weight, food consumption, necropsy, organ weight, hematology and blood chemistry).

Parental animals: Observations and examinations:

CAGE SIDE OBSERVATIONS: Yes

DETAILED CLINICAL OBSERVATIONS: Yes

BODY WEIGHT: Yes

FOOD CONSUMPTION: Yes

HAEMATOLOGY: Yes
- Time schedule for collection of blood: End of the dosing and recovery period.
- How many animals: All animals
- Parameters checked: RBC, WBC, Hb, Plat., MCV, MCH, MCHC, Ret., Eosino., Baso., Mono., Lymph., Neutro., LUC, PT, APTT, Fibrin.,

CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: End of the dosing and recovery period.
- How many animals: All animals
- Parameters checked: ASAT, ALTA, ALP, CPK, T. Bil., T. Prot., Albumin, T. Chol., TGL, PL, Glucosa, BUN, Creat., IP, Ca, Na, K, Cl, α1-glob., α2-glob., β-glob., γ-glob., A/G.

URINALYSIS: Yes (in males)

NEUROBEHAVIOURAL EXAMINATION: Yes
- Battery of functions tested: sensory activity / grip strength / motor activity

Oestrous cyclicity (parental animals):

The following parameters were observed: Frequency of estrous, estrous interval, irregular estrous cycle.

Sperm parameters (parental animals):

Parameters examined in male parental generations: testis weight, epididymis weight.

Litter observations:

PARAMETERS EXAMINED
Clinical signs, external examinations and body weight.

Postmortem examinations (parental animals):

GROSS PATHOLOGY: Yes, all animals at the end of the dosing and recovery periods.
Absolute and relative organ weight:
Males: Adrenals, testis, thymus, spleen, brain, heart, lung, liver, kidney, epididymus, sem. vesic., prostate.
Females: Adrenals, ovaries, thymus, spleen, brain, heart, lung, liver, kidneys.

HISTOPATHOLOGY: Yes, animals within control and highest dose tested (1000 mg/kg bw/day), at the end of dosing and recovery period.
Male: Femoral bone marrow, heart, kidney, liver, lung, prostate, stomach, thyroid, trachea.
Females: Adrenal, femoral bone marrow, heart, kidney, liver, lung, spleen, stomach, thymus, thyroid, trachea, uterus, adipose tissue.

Postmortem examinations (offspring):

SACRIFICE
- Offspring were sacrified at day 4 after birth.

GROSS NECROPSY: Yes

Reproductive indices:

Copulation rate, fertily rate.

Offspring viability indices:

Gestation index, implantation index, delivery index, live birth index (Day 0), sex ratio (Days 0 and 4), viability index (Days 0 and 4).

Clinical signs:

no effects observed

Body weight and weight changes:

no effects observed

Food consumption and compound intake (if feeding study):

no effects observed

Organ weight findings including organ / body weight ratios:

no effects observed

Histopathological findings: non-neoplastic:

no effects observed

Other effects:

no effects observed

Reproductive function: oestrous cycle:

no effects observed

Reproductive function: sperm measures:

not specified

Reproductive performance:

no effects observed

CLINICAL SIGNS AND MORTALITY (PARENTAL ANIMALS)
No animal died in any test article group.
No test article-related changes were observed in clinical signs.
Only test article-colored feces were observed in all groups.

BODY WEIGHT AND FOOD CONSUMPTION (PARENTAL ANIMALS)
No effects were observed.

TEST SUBSTANCE INTAKE (PARENTAL ANIMALS)
No effects were observed.

REPRODUCTIVE FUNCTION: ESTROUS CYCLE (PARENTAL ANIMALS)
No effects were observed.

REPRODUCTIVE FUNCTION: SPERM MEASURES (PARENTAL ANIMALS)
No data reported.

REPRODUCTIVE PERFORMANCE (PARENTAL ANIMALS)
No effects were observed.

ORGAN WEIGHTS (PARENTAL ANIMALS)
No effects were observed.

GROSS PATHOLOGY (PARENTAL ANIMALS)
No effects were observed.

HISTOPATHOLOGY (PARENTAL ANIMALS)
No effects were observed.

OTHER FINDINGS (PARENTAL ANIMALS)
HAEMATOLOGY
No effects were observed.

CLINICAL CHEMISTRY
No effects were observed.

URINALYSIS
No effects were observed in males.

NEUROBEHAVIOUR
No effects were observed.

Dose descriptor:

NOEL

Effect level:

1 000 mg/kg bw/day (nominal)

Based on:

test mat.

Sex:

male/female

Basis for effect level:

other: No adverse effects observed at highest dose

Clinical signs:

no effects observed

Mortality / viability:

no mortality observed

Body weight and weight changes:

no effects observed

Sexual maturation:

not examined

Organ weight findings including organ / body weight ratios:

not specified

Gross pathological findings:

no effects observed

Histopathological findings:

not specified

VIABILITY (OFFSPRING)
No effects were observed.

CLINICAL SIGNS (OFFSPRING)
No effects were observed.

BODY WEIGHT (OFFSPRING)
No effects were observed.

GROSS PATHOLOGY (OFFSPRING)
No effects were observed.

Dose descriptor:

NOEL

Generation:

F1

Effect level:

1 000 mg/kg bw/day (nominal)

Based on:

test mat.

Sex:

male/female

Basis for effect level:

other: No effect observed at highest dose

Reproductive effects observed:

not specified

Fertility and pregnancy data in female rats:

Dose (mg/kg bw/day)	0	40	200	1000
Number of females	12	12	12	12
Frequency of estrous	3.7 ± 0.5	3.8 ± 0.4	3.5 ± 0.7	3.8 ± 0.6
Estrous interval	4.08 ± 0.19	4.08 ± 0.19	4.63 ± 2.01	4.07 ± 0.16
Irregular estrous cycle	0/12	1/12	2/12	1/12
Number of pairs used for mating	12	12	12	12
Number of pairs with suffessful copulation	12	12	12	12
Copulation rate (%)	100.0	100.0	100.0	100.0
Mean copulatory interval (days)	2.3 ± 1.4	2.8 ± 1.9	1.8 ± 0.8	3.0 ± 0.9
Number of fertile pairs	12	11	11	12
Fertility rate (%)	100.0	91.7	91.7	100.0

Not significantly different from control.

Delivery and litter data:

Dose (mg/kg bw/day)	0	40	200	1000
Number of females examined	12	11	11	12
Number of females with live pups	12	11	11	12
Gestation index (%)	100.0	100.0	100.0	100.0
Gestation period (days)	21.96 ± 0.40	21.95 ± 0.42	22.18 ± 0.40	22.13 ± 0.43
Number of corpora lutea	17.6 ± 1.7	16.9 ± 0.42	16.3 ± 2.1	16.1 ± 1.9
Number of implantation sites	15.4 ± 1.9	15.5 ± 2.8	15.5 ± 1.8	14.8 ± 2.1
Implantation index (%)	88.08 ± 11.30	91.63 ± 9.47	95.42 ± 7.66	91.68 ± 7.22
Delivery index (%)	94.27 ± 5.71	90.07 ± 8.41	94.73 ± 3.79	96.18 ± 6.10
Number of pups delivered	14.5 ± 1.8	14.0 ± 3.0	14.6 ± 1.7	14.2 ± 2.1
Number of live pups on Day 0	14.4 ± 1.7	13.5 ± 2.7	14.5 ± 1.8	14.0 ± 1.9
Live birth index (%)	93.78 ± 5.97	87.46 ± 8.50	94.13 ± 4.49	95.18 ± 5.59
Sex ratio on Day 0 (male/total)	0.50 ± 0.11	0.45 ± 0.08	0.49 ± 0.08	0.56 ± 0.14
Viability index on Day 0 (%)	99.48 ± 1.79	97.23 ± 5.55	99.35 ± 2.14	99.02 ± 2.30
Number of live pups on Day 4	14.3 ± 1.6	13.3 ± 2.6	14.2 ± 2.0	13.8 ± 1.9
Sex ratio on Day 4 (male/total)	0.51 ± 0.12	0.47 ± 0.08	0.49 ± 0.08	0.56 ± 0.14
Viability index on Day 4 (%)	98.97 ± 2.41	98.14 ± 4.52	97.26 ± 3.85	98.85 ± 2.69
Body weight of pups Day 0 – Male	6.68 ± 0.33	6.69 ± 0.45	6.68 ± 0.50	6.58 ± 0.37
Body weight of pups Day 0 – Female	6.28 ± 0.44	6.42 ± 0.61	6.35 ± 0.48	6.14 ± 0.43
Body weight of pups Day 4 – Male	10.38 ± 0.78	10.47 ± 1.16	10.60 ± 1.18	9.85 ± 1.14
Body weight of pups Day 4 – Female	9.78 ± 0.86	10.06 ± 1.20	10.12 ± 1.15	9.33 ± 1.10

Not significantly different from control.

Conclusions:

The NOEL/NOAEL for reproductive and developmental toxicity in rats were determined to be 1000 mg/kg bw/day since no effects were observed in the highest dose tested.

Executive summary:

A combined repeated dose toxicity study with the reproduction/developmental screening test was performed with the test item according to OECD Guideline 422 (GLP study). Based on a preliminary 14 -days range-finding study, test item was administered orally to 12 male and female rats at 0 (control), 40, 200 and 1000 mg/kg bw/day for 42 days (from 14 days before mating, and through the mating period until a day before necropsy) and for 41-48 days (from 14 days before mating, and through the mating period until day 4 of lactation) respectively, to evaluate reproductive ability and viability and development of pups. Parental animals were subjected to necropsy at the end of the dosing. Pups were necropsied at Day 5 of lactation. No animals died in any test article group, and no test article related changes were observed in clinical signs, detailed observations, grip strength, locomotor activity, body weight, food consumption, hematology, blood chemistry, urinalysis (only perfomed in males), organ weight, necropsy, or histopathology. Related to the reproductive and devlopmental toxicity parameters, no test article-related changes were observed in any group in estrous cycle examination, copulation rate, fertility rate, gestation period, number of corporea lutea, number of implantations, implantation index, gestation index, delivery inidex, or nursing behaviour in dams. With respect to examination of pups, no test article related changes were observed in the number of pups delivered, number of live pups, live birth index, viability index or sex ration on Day 0 after birh, number of live pups, viability index or sex ration on Day 4 after birth, clinical signs, external examinations, body weight or necropsy. Accordingly, it was considered that the test article did not affect the developmental or growth of next generation. Based on these results, the NOEL/NOAEL for reproductive and developmental toxicity in rats was determined to be 1000 mg/kg bw/day since no effects were observed at the highest dose tested.

Reference 2

Endpoint:

extended one-generation reproductive toxicity - basic test design (Cohorts 1A, and 1B without extension)

Data waiving:

study scientifically not necessary / other information available

Justification for data waiving:

the extended one-generation reproductive toxicity study does not need to be conducted because there are no results from available repeated dose toxicity studies that indicate adverse effects on reproductive organs or tissues, or reveal other concerns in relation with reproductive toxicity

other:

Justification for type of information:

JUSTIFICATION FOR DATA WAIVING
In accordance with column 1 of REACH Annex IX, a two-generation reproductive toxicity study does not need to be conducted since based on the results on the combined repeated dose toxicity study with the reproduction/developmental screening test, no adverse effects were observed on reproductive organs or tissues.

Reason / purpose for cross-reference:

data waiving: supporting information

Reproductive effects observed:

not specified

Effect on fertility: via oral route

Endpoint conclusion:

no adverse effect observed

Dose descriptor:

NOAEL

1 000 mg/kg bw/day

Study duration:

subacute

Species:

rat

Quality of whole database:

The key study is GLP compliant and of high quality (Klimisch score = 1).

Effect on fertility: via inhalation route

Endpoint conclusion:

no study available

Effect on fertility: via dermal route

Endpoint conclusion:

no study available

Additional information

Key study: Experimental results.

Test method according to OECD Guideline 422. GLP study. The NOELs for reproductive and developmental toxicity were considered to be 1000 mg/kg/day for both parental animals and offspring in rats since no effects were observed at highest dose tested.

Short description of key information:

Key study: OECD 422. GLP study. The NOELs for reproductive and developmental toxicity were considered to be 1000 mg/kg bw/day for both parental animals and offspring (no effects at highest dose tested).

Justification for selection of Effect on fertility via oral route:

Only one study available.

Effects on developmental toxicity

Description of key information

Key study: OECD 422. GLP study. The NOELs for reproductive and developmental toxicity were considered to be 1000 mg/kg bw/day for both parental animals and offspring (no effects at highest dose tested).

Link to relevant study records

Reference

Reference 1

Endpoint:

developmental toxicity

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: Test method according to OECD Guideline 422. GLP study.

Qualifier:

according to guideline

Guideline:

other: OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)

GLP compliance:

yes

Limit test:

no

Species:

rat

Strain:

Crj: CD(SD)

Details on test animals or test system and environmental conditions:

- Age at study initiation: 10 weeks old

Route of administration:

oral: gavage

Vehicle:

other: Methylcellulose aqueous solution

Details on exposure:

VEHICLE
- Amount of vehicle (if gavage): 5 mL/kg
- 0.5%w/v Methylcellulose aqueous solution (suspended)

Analytical verification of doses or concentrations:

not specified

Duration of treatment / exposure:

Males: 42 days (from 14 days before mating, and through the mating period until a day before necropsy).
Females: 41-48 days (from 14 days before mating, and through the mating period until day 4 of lactation).

Frequency of treatment:

Daily

Remarks:

Doses / Concentrations:
0 (control), 40, 200 and 1000 mg/kg bw/day
Basis:
nominal conc.

No. of animals per sex per dose:

Males: 7 (control), 12 (40 mg/kg bw/day), 12 (200 mg/Kg bw/day), 7 (1000 mg/kg bw/day), 5 (control with recovery), 5 (1000 mg/kg bw/day with recovery).
Females: 12 (control), 11 (40 mg/kg bw/day), 11 (200 mg/Kg bw/day), 12 (1000 mg/kg bw/day), 5 (control with recovery), 5 (1000 mg/kg bw/day with recovery).

Control animals:

yes, concurrent vehicle

Details on study design:

- Dose selection rationale: In the 14-day range finding study with 5 males and 5 females at dose levels of 0, 100, 300, 1000 mg/kg/day, there were no changes attributed to the treatment at any groups. (Inspection items: clinical signs, body weight, food consumption, necropsy, organ weight, hematology and blood chemistry).

Maternal examinations:

CAGE SIDE OBSERVATIONS: Yes

DETAILED CLINICAL OBSERVATIONS: Yes

BODY WEIGHT: Yes

FOOD CONSUMPTION: Yes

HAEMATOLOGY: Yes
- Time schedule for collection of blood: End of the dosing and recovery period.
- How many animals: All animals
- Parameters checked: RBC, WBC, Hb, Plat., MCV, MCH, MCHC, Ret., Eosino., Baso., Mono., Lymph., Neutro., LUC, PT, APTT, Fibrin.,

CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: End of the dosing and recovery period.
- How many animals: All animals
- Parameters checked: ASAT, ALTA, ALP, CPK, T. Bil., T. Prot., Albumin, T. Chol., TGL, PL, Glucosa, BUN, Creat., IP, Ca, Na, K, Cl, α1-glob., α2-glob., β-glob., γ-glob., A/G.

NEUROBEHAVIOURAL EXAMINATION: Yes
- Battery of functions tested: sensory activity / grip strength / motor activity

POST-MORTEM EXAMINATIONS:
GROSS PATHOLOGY: Yes, all animals at the end of the dosing and recovery periods.
Maternal examinations: Absolute and relative organ weight: Adrenals, ovaries, thymus, spleen, brain, heart, lung, liver, kidneys.

HISTOPATHOLOGY: Yes, animals within control and highest dose tested (1000 mg/kg bw/day), at the end of dosing and recovery period.
Maternal examinations: Adrenal, femoral bone marrow, heart, kidney, liver, lung, spleen, stomach, thymus, thyroid, trachea, uterus, adipose tissue.

Ovaries and uterine content:

The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Number of corpora lutea: Yes
- Number of implantations: Yes

Fetal examinations:

- External examinations: Yes: all per litter

Indices:

Gestation index, implantation index, delivery index, live birth index (Day 0), sex ratio (Days 0 and 4), viability index (Days 0 and 4).

Details on maternal toxic effects:

Maternal toxic effects:no effects

Key result

Dose descriptor:

NOEL

Effect level:

1 000 mg/kg bw/day (nominal)

Based on:

test mat.

Basis for effect level:

other: maternal toxicity

Key result

Dose descriptor:

NOEL

Effect level:

1 000 mg/kg bw/day (nominal)

Based on:

test mat.

Basis for effect level:

other: developmental toxicity

Details on embryotoxic / teratogenic effects:

Embryotoxic / teratogenic effects:no effects

Key result

Dose descriptor:

NOEL

Effect level:

1 000 mg/kg bw/day (nominal)

Based on:

test mat.

Basis for effect level:

other: developmental toxicity

Key result

Abnormalities:

not specified

Key result

Developmental effects observed:

not specified

Delivery and litter data:

Dose (mg/kg bw/day)	0	40	200	1000
Number of females examined	12	11	11	12
Number of females with live pups	12	11	11	12
Gestation index (%)	100.0	100.0	100.0	100.0
Gestation period (days)	21.96 ± 0.40	21.95 ± 0.42	22.18 ± 0.40	22.13 ± 0.43
Number of corpora lutea	17.6 ± 1.7	16.9 ± 0.42	16.3 ± 2.1	16.1 ± 1.9
Number of implantation sites	15.4 ± 1.9	15.5 ± 2.8	15.5 ± 1.8	14.8 ± 2.1
Implantation index (%)	88.08 ± 11.30	91.63 ± 9.47	95.42 ± 7.66	91.68 ± 7.22
Delivery index (%)	94.27 ± 5.71	90.07 ± 8.41	94.73 ± 3.79	96.18 ± 6.10
Number of pups delivered	14.5 ± 1.8	14.0 ± 3.0	14.6 ± 1.7	14.2 ± 2.1
Number of live pups on Day 0	14.4 ± 1.7	13.5 ± 2.7	14.5 ± 1.8	14.0 ± 1.9
Live birth index (%)	93.78 ± 5.97	87.46 ± 8.50	94.13 ± 4.49	95.18 ± 5.59
Sex ratio on Day 0 (male/total)	0.50 ± 0.11	0.45 ± 0.08	0.49 ± 0.08	0.56 ± 0.14
Viability index on Day 0 (%)	99.48 ± 1.79	97.23 ± 5.55	99.35 ± 2.14	99.02 ± 2.30
Number of live pups on Day 4	14.3 ± 1.6	13.3 ± 2.6	14.2 ± 2.0	13.8 ± 1.9
Sex ratio on Day 4 (male/total)	0.51 ± 0.12	0.47 ± 0.08	0.49 ± 0.08	0.56 ± 0.14
Viability index on Day 4 (%)	98.97 ± 2.41	98.14 ± 4.52	97.26 ± 3.85	98.85 ± 2.69
Body weight of pups Day 0 – Male	6.68 ± 0.33	6.69 ± 0.45	6.68 ± 0.50	6.58 ± 0.37
Body weight of pups Day 0 – Female	6.28 ± 0.44	6.42 ± 0.61	6.35 ± 0.48	6.14 ± 0.43
Body weight of pups Day 4 – Male	10.38 ± 0.78	10.47 ± 1.16	10.60 ± 1.18	9.85 ± 1.14
Body weight of pups Day 4 – Female	9.78 ± 0.86	10.06 ± 1.20	10.12 ± 1.15	9.33 ± 1.10

Not significantly different from control.

Conclusions:

The NOEL/NOAEL for reproductive and developmental toxicity in rats were determined to be 1000 mg/kg bw/day since no effects were observed in the highest dose tested.

Executive summary:

A combined repeated dose toxicity study with the reproduction/developmental screening test was performed with the test item according to OECD Guideline 422 (GLP study). Based on a preliminary 14 -days range-finding study, test item was administered orally to 12 male and female rats at 0 (control), 40, 200 and 1000 mg/kg bw/day for 42 days (from 14 days before mating, and through the mating period until a day before necropsy) and for 41-48 days (from 14 days before mating, and through the mating period until day 4 of lactation) respectively, to evaluate reproductive ability and viability and development of pups. Parental animals were subjected to necropsy at the end of the dosing. Pups were necropsied at Day 5 of lactation. No animals died in any test article group, and no test article related changes were observed in clinical signs, detailed observations, grip strength, locomotor activity, body weight, food consumption, hematology, blood chemistry, urinalysis (only performed in males), organ weight, necropsy, or histopathology. Related to the reproductive and developmental toxicity parameters, no test article-related changes were observed in any group in estrous cycle examination, copulation rate, fertility rate, gestation period, number of corporea lutea, number of implantations, implantation index, gestation index, delivery index, or nursing behaviour in dams. With respect to examination of pups, no test article related changes were observed in the number of pups delivered, number of live pups, live birth index, viability index or sex ration on Day 0 after birth, number of live pups, viability index or sex ration on Day 4 after birth, clinical signs, external examinations, body weight or necropsy. Accordingly, it was considered that the test article did not affect the developmental or growth of next generation. Based on these results, the NOEL/NOAEL for reproductive and developmental toxicity in rats was determined to be 1000 mg/kg bw/day since no effects were observed at the highest dose tested.

Reference 2

Endpoint:

developmental toxicity

Data waiving:

study scientifically not necessary / other information available

Justification for data waiving:

other:

Justification for type of information:

JUSTIFICATION FOR DATA WAIVING
A pre-natal developmental toxicity study does not need to be conducted since based on the results on the combined repeated dose toxicity study with the reproduction/developmental screening test, no adverse effects were observed on reproductive organs or tissues.

Reason / purpose for cross-reference:

data waiving: supporting information

Species:

rat

Abnormalities:

not specified

Developmental effects observed:

not specified

Effect on developmental toxicity: via oral route

Endpoint conclusion:

no adverse effect observed

Dose descriptor:

NOAEL

10 000 mg/kg bw/day

Study duration:

subacute

Species:

rat

Quality of whole database:

The key study is GLP compliant and of high quality (Klimisch score = 1).

Effect on developmental toxicity: via inhalation route

Endpoint conclusion:

no study available

Effect on developmental toxicity: via dermal route

Endpoint conclusion:

no study available

Additional information

Key study: OECD 422. GLP study. The NOELs for reproductive and developmental toxicity were considered to be 1000 mg/kg bw/day for both parental animals and offspring (no effects at highest dose tested).

Justification for classification or non-classification

Based on the available information, the substance is not classified for reproduction according to CLP Regulation (EC) no. 1272/2008.